XTNTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Xtant Medical Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.29+0.00 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $40.82M
- P/E (TTM)
- –
- Dividend yield
- –
Xtant Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Market Cap | $40.82M | $229.23M |
| Enterprise Value | $41.96M | $194.73M |
| PS Ratio | 0.37 | 3.14 |
| PB Ratio | 1.02 | 3.19 |
| P/TBV Ratio | 1.21 | 4.69 |
| P/OCF Ratio | 71.62 | 22.23 |
Enterprise value
| Measure | Xtant Medical | Industry median |
|---|---|---|
| EV / Sales | 0.38 | 2.93 |
Income (trailing twelve months)
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Revenue | $109.53M | $102.39M |
| Gross Profit | $65.05M | $60.36M |
| Operating Income | -$10.50M | -$4.31M |
| Pretax Income | -$9.24M | -$2.26M |
| Net Income | -$11.14M | -$6.57M |
| EBITDA | -$6.47M | -$1.98M |
| EPS (Diluted) | -$0.08 | -$0.07 |
Margins
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Gross Margin | 59.4% | 55.1% |
| Operating Margin | -9.58% | -6.04% |
| Pretax Margin | -8.44% | -4.11% |
| Profit Margin | -10.2% | -10.5% |
| EBITDA Margin | -5.91% | -2.67% |
| FCF Margin | -0.64% | -0.30% |
Returns
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Return on Equity (ROE) | -25.2% | -19.2% |
| Return on Assets (ROA) | -12.2% | -13.3% |
| Return on Invested Capital (ROIC) | -15.8% | -4.11% |
| Return on Capital Employed (ROCE) | -21.1% | -9.07% |
Growth
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -14.3% | 8.85% |
| Revenue Growth (3Y CAGR) | 32.2% | 7.08% |
| Revenue Growth (5Y CAGR) | 20.2% | 11.8% |
Balance sheet
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.87M | $37.33M |
| Total Debt | $11.01M | $72.66M |
| Net Cash (Debt) | -$1.14M | $3.92M |
| Net Cash Per Share | -$0.01 | $0.28 |
| Equity (Book Value) | $40.02M | $57.36M |
| Book Value Per Share | $0.29 | $2.81 |
| Tangible Book Value | $33.69M | $10.71M |
| Working Capital | $34.81M | $54.64M |
Financial position
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Current Ratio | 2.16 | 2.50 |
| Quick Ratio | 0.98 | 1.54 |
| Debt / Equity | 0.28 | 0.38 |
| Interest Coverage | -3.80 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Operating Cash Flow | $570.00K | -$653.46K |
| Capital Expenditures | -$1.27M | -$3.69M |
| Free Cash Flow | -$696.00K | -$835.02K |
| FCF Per Share | -$0.00 | -$0.02 |
Efficiency
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Asset Turnover | 1.20 | 0.59 |
| Inventory Turnover | 1.21 | 2.21 |
| Revenue Per Employee | $725.34K | $322.75K |
| Profits Per Employee | -$73.76K | -$52.11K |
| Employee Count | 151 | 197 |
Dividends and yields
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Earnings Yield | -27.3% | -6.92% |
| FCF Yield | -1.70% | -0.62% |
Shares
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Shares Outstanding | 140,288,000 | 44,856,700 |
| Shares Change (YoY) | 2.67% | 3.35% |
| Shares Change (QoQ) | 0.14% | 0.27% |
| Shares Held by Institutions | 106.0% | 63.5% |
Taxes
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Income Tax | $1.90M | $1.52M |
Scores
| Measure | Xtant Medical | Industry median |
|---|---|---|
| Altman Z-Score | -2.61 | 1.95 |
| Piotroski F-Score | 8 | 5 |
| Beneish M-Score | -3.11 | -2.64 |
Calculated by StockData from Xtant Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.